title: [Good response to intravenous immunoglobulin therapy in sensory dominant distal variant of chronic inflammatory demyelinating polyneuropathy].
abstract: A 46-year-old man experienced numbness and muscle weakness in the distal portions of both hands, which progressed over following three months. Neurological examination showed mild muscle weakness only in distal arms, hypoflexia or areflexia, and hypesthesia in glove and stocking distribution. Motor conduction study revealed markedly prolonged distal latency and abnormal temporal dispersion. Sensory nerve potentials were reduced or could not be recorded. Histopathlogical findings of the sural nerve showed several nerve fibers with thinning myelin sheath and mild reduction of myelinated fibers. These results suggested the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Two weeks after intravenous immunoglobulin therapy, neurological deficits rapidly improved and electrophysiological abnormalities were also ameliorated. Thereafter, there was no clinical deterioration for two years without further treatment. Our patient suggested that immunomodulating treatment is needed for stopping the initial progression of neurological deficits, but maintenance therapy is not always necessary for keeping the remitting state in distal variant of CIDP.
authors.forename: Yukio
authors.initials: Y
authors.lastname: Takeshita
authors.forename: Michiaki
authors.initials: M
authors.lastname: Koga
authors.forename: Masatoshi
authors.initials: M
authors.lastname: Omoto
authors.forename: Jun-Ichi
authors.initials: J
authors.lastname: Ogasawara
authors.forename: Motoharu
authors.initials: M
authors.lastname: Kawai
authors.forename: Takashi
authors.initials: T
authors.lastname: Kanda
mesh_terms: D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000188:drug therapy* / Q000503:physiopathology; D011984:Sensory Receptor Cells / Q000502:physiology; D016896:Treatment Outcome
chemical_list: D016756:Immunoglobulins, Intravenous